IK Investment Partners (“IK”) is pleased to announce that the IK VIII Fund has reached an agreement to acquire Ellab A/S (“Ellab” or “the Company”), a leading manufacturer of thermal validation solutions, primarily used for validation for food and pharmaceutical industries, from a group of private investors. Financial terms of the transaction are not disclosed.

Founded in 1949, Ellab is a leading global supplier of solutions for measuring, recording, monitoring and validating critical parameters of thermal processing, selling its products in over 65 countries across the globe. The Company offers a wide product range of high-precision systems for temperature, pressure and humidity monitoring and validation based on either data loggers or thermocouple based wired instruments. Ellab’s products are used by the pharmaceutical and food industry as well as hospitals, where accurate and complete documentation is essential.